Log in

NASDAQ:ARCTArcturus Therapeutics News Headlines

$58.27
+4.17 (+7.71 %)
(As of 05/25/2020 04:00 PM ET)
Add
Compare
Today's Range
$54.39
Now: $58.27
$60.70
50-Day Range
$12.99
MA: $31.80
$58.27
52-Week Range
$5.75
Now: $58.27
$62.97
Volume503,116 shs
Average Volume1.04 million shs
Market Capitalization$1.16 billion
P/E RatioN/A
Dividend YieldN/A
Beta3.19

Headlines

Arcturus Therapeutics (NASDAQ ARCT) News Headlines

Source:
DateHeadline
Arcturus CEO on How Messenger RNA Vaccines WorkArcturus CEO on How Messenger RNA Vaccines Work
www.thestreet.com - May 25 at 2:51 PM
Arcturus CEO on Possibility of COVID-19 Vaccine By End of 2020Arcturus CEO on Possibility of COVID-19 Vaccine By End of 2020
www.thestreet.com - May 25 at 9:49 AM
Arcturus CEO on Vaccine Candidate, Modernas VaccineArcturus CEO on Vaccine Candidate, Moderna's Vaccine
www.thestreet.com - May 22 at 5:25 PM
Ultragenyx Announces Exercise of Option to Purchase Additional Stock of Arcturus TherapeuticsUltragenyx Announces Exercise of Option to Purchase Additional Stock of Arcturus Therapeutics
finance.yahoo.com - May 21 at 11:22 AM
Thinking about trading stocks and options in Arcturus Therapeutics, Novavax, Spirit Airlines, Aquestive Therapeutics, or Penn National Gaming?Thinking about trading stocks and options in Arcturus Therapeutics, Novavax, Spirit Airlines, Aquestive Therapeutics, or Penn National Gaming?
www.prnewswire.com - May 18 at 1:21 PM
Arcturus Therapeutics Ltd (NASDAQ:ARCT) Given Consensus Rating of "Buy" by AnalystsArcturus Therapeutics Ltd (NASDAQ:ARCT) Given Consensus Rating of "Buy" by Analysts
www.americanbankingnews.com - May 14 at 5:53 PM
Arcturus Therapeutics Sees Unusually High Options Volume (NASDAQ:ARCT)Arcturus Therapeutics Sees Unusually High Options Volume (NASDAQ:ARCT)
www.americanbankingnews.com - May 13 at 6:46 AM
Investors Buy High Volume of Arcturus Therapeutics Call Options (NASDAQ:ARCT)Investors Buy High Volume of Arcturus Therapeutics Call Options (NASDAQ:ARCT)
www.americanbankingnews.com - May 12 at 7:28 PM
Is Arcturus Therapeutics (ARCT) Stock a Solid Choice Right Now?Is Arcturus Therapeutics (ARCT) Stock a Solid Choice Right Now?
finance.yahoo.com - May 12 at 6:34 PM
Arcturus Therapeutics Ltd (NASDAQ:ARCT) Sees Large Increase in Short InterestArcturus Therapeutics Ltd (NASDAQ:ARCT) Sees Large Increase in Short Interest
www.americanbankingnews.com - May 11 at 8:10 PM
Arcturus Therapeutics (ARCT) CEO Joseph Payne on Q1 2020 Results - Earnings Call TranscriptArcturus Therapeutics' (ARCT) CEO Joseph Payne on Q1 2020 Results - Earnings Call Transcript
seekingalpha.com - May 11 at 9:08 AM
Arcturus Therapeutics Holdings Inc. (ARCT) Q1 2020 Earnings Call TranscriptArcturus Therapeutics Holdings Inc. (ARCT) Q1 2020 Earnings Call Transcript
finance.yahoo.com - May 10 at 7:21 AM
Arcturus Therapeutics (NASDAQ:ARCT) Posts  Earnings Results, Misses Estimates By $0.08 EPSArcturus Therapeutics (NASDAQ:ARCT) Posts Earnings Results, Misses Estimates By $0.08 EPS
www.americanbankingnews.com - May 10 at 12:50 AM
The Global RNA Interference Technology Market is...The Global RNA Interference Technology Market is...
www.benzinga.com - May 8 at 11:17 PM
BRIEF-Arcturus Therapeutics Files For Mixed Shelf Of Upto $200 MillionBRIEF-Arcturus Therapeutics Files For Mixed Shelf Of Upto $200 Million
www.reuters.com - May 8 at 11:17 PM
Arcturus up on new preclinical data on COVID-19 vaccineArcturus up on new preclinical data on COVID-19 vaccine
seekingalpha.com - May 8 at 6:16 PM
Arcturus Reports Additional Supportive Preclinical Data for its COVID-19 Vaccine Candidate (LUNAR-COV19)Arcturus Reports Additional Supportive Preclinical Data for its COVID-19 Vaccine Candidate (LUNAR-COV19)
finance.yahoo.com - May 8 at 6:16 PM
Arcturus Therapeutics EPS misses by $0.08, misses on revenueArcturus Therapeutics EPS misses by $0.08, misses on revenue
seekingalpha.com - May 7 at 6:06 PM
Arcturus Therapeutics Announces First Quarter 2020 Financial Results and Provides a Corporate UpdateArcturus Therapeutics Announces First Quarter 2020 Financial Results and Provides a Corporate Update
finance.yahoo.com - May 7 at 6:06 PM
$7.52 Million in Sales Expected for Arcturus Therapeutics Ltd (NASDAQ:ARCT) This Quarter$7.52 Million in Sales Expected for Arcturus Therapeutics Ltd (NASDAQ:ARCT) This Quarter
www.americanbankingnews.com - May 6 at 2:44 AM
Arcturus Therapeutics (ARCT) Scheduled to Post Earnings on ThursdayArcturus Therapeutics (ARCT) Scheduled to Post Earnings on Thursday
www.americanbankingnews.com - May 5 at 7:09 PM
As Arcturus Therapeutics Holdings Inc hits a yearly high, is it too late to buy shares?As Arcturus Therapeutics Holdings Inc hits a yearly high, is it too late to buy shares?
uk.finance.yahoo.com - May 5 at 7:51 AM
BRIEF-Arcturus Therapeutics, Catalent Announce Partnership To Manufacture Covid-19 VaccineBRIEF-Arcturus Therapeutics, Catalent Announce Partnership To Manufacture Covid-19 Vaccine
www.reuters.com - May 4 at 4:10 PM
Arcturus Therapeutics to Report First Quarter 2020 Financial Results and Provide a Corporate Update on May 7, 2020Arcturus Therapeutics to Report First Quarter 2020 Financial Results and Provide a Corporate Update on May 7, 2020
finance.yahoo.com - May 4 at 4:10 PM
Zacks: Brokerages Anticipate Arcturus Therapeutics Ltd (NASDAQ:ARCT) to Announce -$0.49 Earnings Per ShareZacks: Brokerages Anticipate Arcturus Therapeutics Ltd (NASDAQ:ARCT) to Announce -$0.49 Earnings Per Share
www.americanbankingnews.com - May 4 at 3:57 PM
Arcturus Therapeutics (NASDAQ:ARCT) Rating Reiterated by HC WainwrightArcturus Therapeutics (NASDAQ:ARCT) Rating Reiterated by HC Wainwright
www.americanbankingnews.com - May 4 at 11:59 AM
Arcturus Therapeutics and Catalent Announce Partnership to Manufacture mRNA-Based COVID-19 VaccineArcturus Therapeutics and Catalent Announce Partnership to Manufacture mRNA-Based COVID-19 Vaccine
finance.yahoo.com - May 4 at 8:51 AM
CORRECTED-BRIEF-Arcturus Reports Positive Preclinical Data For Covid-19 Vaccine Candidate (April 27)CORRECTED-BRIEF-Arcturus Reports Positive Preclinical Data For Covid-19 Vaccine Candidate (April 27)
www.reuters.com - April 28 at 1:46 PM
Arcturus Spikes 24% on Positive Preclinical Data For COVID-19 Vaccine CandidateArcturus Spikes 24% on Positive Preclinical Data For COVID-19 Vaccine Candidate
www.nasdaq.com - April 27 at 10:45 PM
Familial Amyloid Polyneuropathy Therapeutics Market | Size, Growth, Trends, Regional Forecast And Industry Trends Analysis 2020-2026Familial Amyloid Polyneuropathy Therapeutics Market | Size, Growth, Trends, Regional Forecast And Industry Trends Analysis 2020-2026
www.marketwatch.com - April 27 at 12:44 PM
BRIEF-Arcturus Reports Positive Preclinical Data For Covid-19 Vaccine CandidateBRIEF-Arcturus Reports Positive Preclinical Data For Covid-19 Vaccine Candidate
www.reuters.com - April 27 at 7:43 AM
Arcturus Reports Positive Preclinical Data for its COVID-19 Vaccine CandidateArcturus Reports Positive Preclinical Data for its COVID-19 Vaccine Candidate
finance.yahoo.com - April 27 at 7:43 AM
Arcturus Therapeutics Announces Closing of Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional SharesArcturus Therapeutics Announces Closing of Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
finance.yahoo.com - April 21 at 8:16 AM
Arcturus prices stock offering at $17Arcturus prices stock offering at $17
seekingalpha.com - April 16 at 12:07 PM
Arcturus Therapeutics Announces Pricing of $70.0 Million Public Offering of Common StockArcturus Therapeutics Announces Pricing of $70.0 Million Public Offering of Common Stock
finance.yahoo.com - April 16 at 12:07 PM
Arcturus Therapeutics Announces Proposed Public Offering of Common StockArcturus Therapeutics Announces Proposed Public Offering of Common Stock
finance.yahoo.com - April 15 at 9:01 PM
BRIEF-Arcturus Announces Approval Of Clinical Trial Application For ARCT-810BRIEF-Arcturus Announces Approval Of Clinical Trial Application For ARCT-810
www.reuters.com - April 13 at 9:04 AM
Arcturus Therapeutics Announces Allowance of IND & Approval of Clinical Trial Application (CTA) for ARCT-810, a First-in-Class Investigational mRNA Medicine to Treat Ornithine Transcarbamylase DeficiencyArcturus Therapeutics Announces Allowance of IND & Approval of Clinical Trial Application (CTA) for ARCT-810, a First-in-Class Investigational mRNA Medicine to Treat Ornithine Transcarbamylase Deficiency
finance.yahoo.com - April 13 at 9:04 AM
Arcturus Therapeutics Announces Clinical Trial Timeline for its COVID-19 VaccineArcturus Therapeutics Announces Clinical Trial Timeline for its COVID-19 Vaccine
finance.yahoo.com - April 9 at 8:54 AM
Arcturus bullish on Duke system in Covid-19 vaccine developmentArcturus bullish on Duke system in Covid-19 vaccine development
seekingalpha.com - March 27 at 1:09 PM
Arcturus COVID-19 Vaccine to Benefit from Duke-NUS Genetic Correlation SystemArcturus COVID-19 Vaccine to Benefit from Duke-NUS Genetic Correlation System
finance.yahoo.com - March 27 at 8:09 AM
Singapore Scientists Study Genes to Fast-Track Coronavirus VaccineSingapore Scientists Study Genes to Fast-Track Coronavirus Vaccine
www.nytimes.com - March 24 at 9:34 AM
Global Equities Tumble on Fears Governments Will Need More Stimulus to Battle Coronavirus EffectsGlobal Equities Tumble on Fears Governments Will Need More Stimulus to Battle Coronavirus Effects
www.barrons.com - March 18 at 8:23 AM
Arcturus Therapeutics Holdings Inc. Analysts Are Pretty Bullish On The Stock After Recent ResultsArcturus Therapeutics Holdings Inc. Analysts Are Pretty Bullish On The Stock After Recent Results
finance.yahoo.com - March 14 at 12:39 PM
Arcturus Therapeutics (ARCT) Reports Q4 Loss, Lags Revenue EstimatesArcturus Therapeutics (ARCT) Reports Q4 Loss, Lags Revenue Estimates
finance.yahoo.com - March 11 at 10:16 PM
Arcturus Therapeutics EPS misses by $0.25, misses on revenueArcturus Therapeutics EPS misses by $0.25, misses on revenue
seekingalpha.com - March 11 at 5:16 PM
BRIEF-Arcturus Therapeutics Reports Fourth Quarter And Year End 2019 Financial ResultsBRIEF-Arcturus Therapeutics Reports Fourth Quarter And Year End 2019 Financial Results
www.reuters.com - March 11 at 5:16 PM
Arcturus Therapeutics Holdings Inc to Host Earnings CallArcturus Therapeutics Holdings Inc to Host Earnings Call
finance.yahoo.com - March 11 at 5:16 PM
Arcturus Therapeutics Reports Fourth Quarter and Year End 2019 Financial ResultsArcturus Therapeutics Reports Fourth Quarter and Year End 2019 Financial Results
finance.yahoo.com - March 11 at 5:16 PM
Coronavirus Vaccine Makes This Stock a “Strong Buy”Coronavirus Vaccine Makes This Stock a “Strong Buy”
finance.yahoo.com - March 6 at 12:17 PM
This page was last updated on 5/26/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.